Gabapentin is not a barbiturate. It belongs to a completely different drug class called anticonvulsants, and it works through a mechanism that has nothing in common with how barbiturates affect the brain. The confusion likely stems from the fact that both drugs can treat seizures and both carry some risk of misuse, but the similarities end there.
How Gabapentin Actually Works
Gabapentin was originally designed as a synthetic version of GABA, a calming chemical messenger in the brain. Its name even reflects this: “gaba-pentin.” But researchers later discovered that gabapentin doesn’t actually interact with GABA receptors or GABA transporters at all. Instead, it binds to a specific part of calcium channels on nerve cells, called the alpha-2-delta subunit. Over time, this binding reduces the number of calcium channels available on the cell surface, which dials down excessive nerve signaling. That’s how it helps control seizures and nerve pain.
The FDA has approved gabapentin for two conditions: nerve pain following shingles (postherpetic neuralgia) in adults, and as an add-on treatment for partial seizures in adults and children aged 3 and older. Doctors also prescribe it off-label for a range of other pain and anxiety-related conditions.
How Barbiturates Work Differently
Barbiturates target a completely different system in the brain. They bind directly to GABA-A receptors, which are chloride channels that quiet brain activity when activated. When a barbiturate attaches to this receptor, it forces the channel to stay open longer than it normally would, flooding the cell with chloride ions and producing strong sedation. At higher doses, barbiturates can activate these receptors even without GABA present, which is why overdose can suppress breathing and become fatal.
This is fundamentally different from gabapentin’s mechanism. Gabapentin doesn’t touch GABA receptors, doesn’t enhance chloride flow, and doesn’t produce the deep sedation that barbiturates are known for. The two drugs are as pharmacologically distinct as aspirin and an antibiotic.
Why Barbiturates Have Largely Disappeared
Barbiturates were once among the most commonly prescribed medications for anxiety, insomnia, and seizures. Today their use is narrow and specific. Phenobarbital remains a go-to for neonatal and pediatric seizures and is still the most affordable epilepsy treatment in low-resource countries. Butalbital shows up in combination headache medications. Pentobarbital is reserved for severe situations like refractory status epilepticus or dangerously elevated brain pressure after traumatic injury. Methohexital sees limited use in electroconvulsive therapy and brief procedural sedation.
The reason barbiturates fell out of favor is straightforward: they carry a high risk of fatal overdose, physical dependence develops quickly, and the gap between a therapeutic dose and a lethal dose is dangerously small. Benzodiazepines replaced them for most uses in the 1970s and 1980s, and newer anticonvulsants like gabapentin replaced them for many seizure applications.
Gabapentin’s Controlled Substance Status
One reason people compare gabapentin to barbiturates is that both have abuse potential. Barbiturates are tightly controlled as Schedule II, III, or IV substances at the federal level, depending on the specific drug. Gabapentin is not federally scheduled at all under the Controlled Substances Act.
However, states have increasingly added their own restrictions. As of the end of 2024, seven U.S. jurisdictions classify gabapentin as a Schedule V controlled substance (the lowest category), and 17 additional jurisdictions require pharmacies to report gabapentin prescriptions to prescription drug monitoring programs without formally scheduling it. That means roughly half the country has some form of enhanced tracking for gabapentin prescriptions.
These restrictions reflect real patterns of misuse. In the general population, gabapentin misuse sits around 1%. But among people who misuse opioids, the rate jumps to 15 to 22%. Gabapentin is rarely misused alone. In one study of driving impairment cases involving gabapentin, only 7% of positive blood samples contained gabapentin by itself. The rest involved combinations with benzodiazepines, opioids, antidepressants, or other sedating drugs. In postmortem toxicology reports from Scotland, 75% of cases involving gabapentin also showed the presence of morphine or methadone.
Key Differences at a Glance
- Drug class: Gabapentin is an anticonvulsant. Barbiturates are sedative-hypnotics.
- Brain target: Gabapentin acts on calcium channel subunits. Barbiturates act on GABA-A receptors.
- Overdose risk: Gabapentin has a wide safety margin on its own. Barbiturates have a narrow margin between effective and lethal doses.
- Federal scheduling: Gabapentin is unscheduled federally. Most barbiturates are Schedule II through IV.
- Dependence potential: Gabapentin can cause withdrawal symptoms after prolonged use, but physical dependence develops more slowly and is less severe than with barbiturates.
- Sedation: Gabapentin may cause drowsiness. Barbiturates produce deep, dose-dependent sedation that can suppress breathing.
If you’ve been prescribed gabapentin and were wondering whether you’re taking a barbiturate, the answer is a clear no. The two medications share almost nothing in common beyond the fact that both can be used for seizures. Their chemistry, their effects on the brain, their safety profiles, and their legal classifications are all distinct.